Literature DB >> 8544846

Alternative leader sequences in insulin-like growth factor I mRNAs modulate translational efficiency and encode multiple signal peptides.

H Yang1, M L Adamo, A P Koval, M C McGuinness, H Ben-Hur, Y Yang, D LeRoith, C T Roberts.   

Abstract

Rat insulin-like growth factor I (IGF-I) mRNAs contain multiple 5'-untranslated regions due to the use of leader exons transcribed from several transcription initiation sites and to alternative splicing within leader exon 1. Synthetic RNAs with 5'-ends corresponding to the use of exon 1 transcription initiation sites were translated in vitro into prepro-IGF-I peptides initiated at a Met-48 codon in exon 1 or a Met-22 codon in exon 3, and RNAs with a 5'-end corresponding to the major exon 2 transcription start site were translated into a prepro-IGF-I peptide initiated at a Met-32 codon in exon 2. All forms of prepro-IGF-I were processed by canine pancreatic microsomes, suggesting that all these prepeptides function as signal peptides. The translational efficiency of IGF-I RNAs was inversely proportional to the length of the 5'-untranslated region. Mutation of the first of three upstream AUG codons in exon 1, which potentially initiates a 14-amino acid open reading frame, did not affect prepro-IGF-I translation. The other two AUG codons are immediately followed by stop codons. The absence of both upstream AUG codons in a completely spliced exon 1-derived RNA enhanced the in vitro and in vivo translatability of this RNA as compared with the full-length RNA. Mutation of the downstream initiation codon in particular increased translational efficiency in vitro and in intact cells, suggesting that an inefficient reinitiation event at the Met-48 codon contributes to the poorer translation of IGF-I mRNAs in which these upstream AUGUGA motifs occur. We conclude that IGF-I mRNAs potentially encode multiple forms of preproIGF and that specific differences in their 5'-untranslated regions provide a molecular basis for translational control of IGF-I biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8544846     DOI: 10.1210/mend.9.10.8544846

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  13 in total

1.  Long-distance chromatin interaction of IGF1 during embryonic and postnatal development in the liver of Sus scrofa.

Authors:  Jinbi Zhang; Wang Yao; Zengxiang Pan; Honglin Liu
Journal:  Funct Integr Genomics       Date:  2021-01-06       Impact factor: 3.410

Review 2.  The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity.

Authors:  Anastassios Philippou; Maria Maridaki; Spiros Pneumaticos; Michael Koutsilieris
Journal:  Mol Med       Date:  2014-05-07       Impact factor: 6.354

3.  Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice.

Authors:  J Wang; W Niu; Y Nikiforov; S Naito; S Chernausek; D Witte; D LeRoith; A Strauch; J A Fagin
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

4.  Inhibition of gene expression by anti-sense C-5 propyne oligonucleotides detected by a reporter enzyme.

Authors:  Y Hamel; J Lacoste; C Frayssinet; A Sarasin; T Garestier; J C François; C Hélène
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

Review 5.  Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration.

Authors:  Ronald W Matheny; Bradley C Nindl; Martin L Adamo
Journal:  Endocrinology       Date:  2010-02-03       Impact factor: 4.736

Review 6.  Posttranscriptional regulation of insulin family ligands and receptors.

Authors:  Amaresh C Panda; Ioannis Grammatikakis; Je-Hyun Yoon; Kotb Abdelmohsen
Journal:  Int J Mol Sci       Date:  2013-09-18       Impact factor: 5.923

7.  The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth.

Authors:  Meriem Ouni; Yasemin Gunes; Marie-Pierre Belot; Anne-Laure Castell; Delphine Fradin; Pierre Bougnères
Journal:  Clin Epigenetics       Date:  2015-03-13       Impact factor: 6.551

8.  Anabolic effects of IGF-1 signaling on the skeleton.

Authors:  Candice G T Tahimic; Yongmei Wang; Daniel D Bikle
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-04       Impact factor: 5.555

9.  The Regulation of IGF-1 Gene Transcription and Splicing during Development and Aging.

Authors:  A M Oberbauer
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-26       Impact factor: 5.555

10.  Nucleolar localization of an isoform of the IGF-I precursor.

Authors:  Daniel S-W Tan; Alexandra Cook; Shern L Chew
Journal:  BMC Cell Biol       Date:  2002-07-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.